Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Waldenstrom's Macroglobulinemia: An Update.

Mazzucchelli M, Frustaci AM, Deodato M, Cairoli R, Tedeschi A.

Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018004. doi: 10.4084/MJHID.2018.004. eCollection 2018. Review.

2.

Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.

Varettoni M, Zibellini S, Defrancesco I, Ferretti VV, Rizzo E, Malcovati L, Gallì A, Porta MGD, Boveri E, Arcaini L, Candido C, Paulli M, Cazzola M.

Haematologica. 2017 Dec;102(12):2077-2085. doi: 10.3324/haematol.2017.172718. Epub 2017 Oct 5.

3.

New developments in the management of Waldenström macroglobulinemia.

Abeykoon JP, Yanamandra U, Kapoor P.

Cancer Manag Res. 2017 Mar 10;9:73-83. doi: 10.2147/CMAR.S94059. eCollection 2017. Review.

4.

Evolution of Management and Outcomes in Waldenström Macroglobulinemia: A Population-Based Analysis.

Olszewski AJ, Treon SP, Castillo JJ.

Oncologist. 2016 Jul 29. pii: theoncologist.2016-0126. [Epub ahead of print]

5.

Waldenström's macroglobulinemia: a clinical perspective in the era of novel therapeutics.

Dimopoulos MA, Kastritis E, Ghobrial IM.

Ann Oncol. 2016 Feb;27(2):233-40. doi: 10.1093/annonc/mdv572. Epub 2015 Nov 23. Review.

6.

Familial predisposition and genetic risk factors for lymphoma.

Cerhan JR, Slager SL.

Blood. 2015 Nov 12;126(20):2265-73. doi: 10.1182/blood-2015-04-537498. Epub 2015 Sep 24. Review.

7.

Rare Circulating Cells in Familial Waldenström Macroglobulinemia Displaying the MYD88 L265P Mutation Are Enriched by Epstein-Barr Virus Immortalization.

Pertesi M, Galia P, Nazaret N, Vallée M, Garderet L, Leleu X, Avet-Loiseau H, Foll M, Byrnes G, Lachuer J, McKay JD, Dumontet C.

PLoS One. 2015 Sep 9;10(9):e0136505. doi: 10.1371/journal.pone.0136505. eCollection 2015.

8.

Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis.

Cao X, Ye Q, Orlowski RZ, Wang X, Loghavi S, Tu M, Thomas SK, Shan J, Li S, Qazilbash M, Yin CC, Weber D, Miranda RN, Xu-Monette ZY, Medeiros LJ, Young KH.

J Hematol Oncol. 2015 Jun 24;8:74. doi: 10.1186/s13045-015-0172-y.

9.

Population-based study on the impact of the familial form of Waldenström macroglobulinemia on overall survival.

Steingrímsson V, Lund SH, Turesson I, Goldin LR, Björkholm M, Landgren O, Kristinsson SY.

Blood. 2015 Mar 26;125(13):2174-5. doi: 10.1182/blood-2015-01-622068. No abstract available.

10.

Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Vajdic CM, Landgren O, McMaster ML, Slager SL, Brooks-Wilson A, Smith A, Staines A, Dogan A, Ansell SM, Sampson JN, Morton LM, Linet MS.

J Natl Cancer Inst Monogr. 2014 Aug;2014(48):87-97. doi: 10.1093/jncimonographs/lgu002.

11.

Primary bone lymphoplasmacytic lymphoma presenting with spinal cord compression: a case report.

Lei Y, Zi L, Long S, Pei L, Wei L.

Turk J Haematol. 2013 Dec;30(4):409-12. doi: 10.4274/Tjh.2012.0072. Epub 2013 Dec 5.

12.
13.

Candidate genes of Waldenström's macroglobulinemia: current evidence and research.

Bianchi G, Sacco A, Kumar S, Rossi G, Ghobrial I, Roccaro A.

Appl Clin Genet. 2013 Jul 17;6:33-42. doi: 10.2147/TACG.S42690. Print 2013.

14.

Precursors to lymphoproliferative malignancies.

Goldin LR, McMaster ML, Caporaso NE.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):533-9. doi: 10.1158/1055-9965.EPI-12-1348. Review.

15.

Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.

Greenberg AJ, Rajkumar SV, Vachon CM.

Blood. 2012 Jun 7;119(23):5359-66. doi: 10.1182/blood-2011-11-387324. Epub 2012 Feb 21. Review.

16.

Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.

Kristinsson SY, Goldin LR, Turesson I, Björkholm M, Landgren O.

Acta Haematol. 2012;127(3):173-7. doi: 10.1159/000335618. Epub 2012 Feb 3. Review.

17.

Host genetics in follicular lymphoma.

Cerhan JR.

Best Pract Res Clin Haematol. 2011 Jun;24(2):121-34. doi: 10.1016/j.beha.2011.02.004. Epub 2011 May 5. Review.

18.

Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders.

Awan H, Jønsson V, Johannesen TB, Ly B, Tjønnfjord GE.

Transl Oncogenomics. 2010 Mar 30;4:1-9.

19.

Familial Aspects of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and Related Lymphomas.

Goldin LR, Landgren O, Marti GE, Caporaso NE.

European J Clin Med Oncol. 2010 Feb;2(1):119-126.

20.

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.

Rumi E, Passamonti F, Elena C, Pietra D, Arcaini L, Astori C, Zibellini S, Boveri E, Pascutto C, Lazzarino M.

Haematologica. 2011 Mar;96(3):454-8. doi: 10.3324/haematol.2010.033779. Epub 2010 Nov 25.

Supplemental Content

Support Center